Skip to main content
. 2021 Sep 19;11(9):1242. doi: 10.3390/brainsci11091242

Table 3.

Treatments with different AAPs in the whole sample. Continuous variables expressed as mean (±SD).

Variables Olanzapine Aripiprazole Risperidone Quetiapine
N. of patients treated 32 (47.1%) 25 (36.7%) 14 (20.6%) 8 (11.8%)
Mean maximum dosage (in mg) 6.1 (±2.3) 10.4 (±3.4) 0.7 (±0.3) 125.0 (±97.3)
Admission-discharge BMI difference (in kg/m2) 2.2 (±1.3) 1.7 (±1.5) 2.7 (±1.2) 1.2 (±1.2)
p-value of differences in Admission-discharge BMI difference 0.205 0.279 0.033 0.112
LOS (in days) 138.6 (±81.9) 146.9 (±71.3) 96.0 (±30.0) 165.5 (±153.6)
p-value of differences in LOS (in days) 0.902 0.083 0.022 0.917

Abbreviations: BMI: body-mass index; LOS: length of in-hospital stay. Note: Bonferroni-corrected significance level = 0.05/4 = 0.0125.